nodes	percent_of_prediction	percent_of_DWPC	metapath
Naratriptan—HTR1B—artery—uterine cancer	0.00626	0.185	CbGeAlD
Naratriptan—HTR1D—artery—uterine cancer	0.00606	0.18	CbGeAlD
Naratriptan—MAOA—myometrium—uterine cancer	0.00223	0.066	CbGeAlD
Naratriptan—HTR1A—renal system—uterine cancer	0.00178	0.0526	CbGeAlD
Naratriptan—HTR1B—female reproductive system—uterine cancer	0.00176	0.0522	CbGeAlD
Naratriptan—MAOA—uterine cervix—uterine cancer	0.00173	0.0514	CbGeAlD
Naratriptan—HTR1D—female reproductive system—uterine cancer	0.00171	0.0506	CbGeAlD
Naratriptan—MAOA—decidua—uterine cancer	0.00165	0.049	CbGeAlD
Naratriptan—MAOA—renal system—uterine cancer	0.00162	0.0481	CbGeAlD
Naratriptan—MAOA—endometrium—uterine cancer	0.00157	0.0465	CbGeAlD
Naratriptan—MAOA—mammalian vulva—uterine cancer	0.00152	0.045	CbGeAlD
Naratriptan—MAOA—uterus—uterine cancer	0.00145	0.0428	CbGeAlD
Naratriptan—Discomfort—Dactinomycin—uterine cancer	0.00139	0.00143	CcSEcCtD
Naratriptan—Bladder pain—Epirubicin—uterine cancer	0.00138	0.00143	CcSEcCtD
Naratriptan—Cystitis noninfective—Doxorubicin—uterine cancer	0.00138	0.00143	CcSEcCtD
Naratriptan—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00137	0.00142	CcSEcCtD
Naratriptan—Cystitis—Doxorubicin—uterine cancer	0.00137	0.00141	CcSEcCtD
Naratriptan—Asthenia—Progesterone—uterine cancer	0.00137	0.00141	CcSEcCtD
Naratriptan—Hypoaesthesia—Etoposide—uterine cancer	0.00136	0.00141	CcSEcCtD
Naratriptan—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.00136	0.00141	CcSEcCtD
Naratriptan—Pruritus—Progesterone—uterine cancer	0.00135	0.00139	CcSEcCtD
Naratriptan—Oedema—Dactinomycin—uterine cancer	0.00134	0.00139	CcSEcCtD
Naratriptan—Fluid retention—Doxorubicin—uterine cancer	0.00134	0.00139	CcSEcCtD
Naratriptan—Infection—Dactinomycin—uterine cancer	0.00134	0.00138	CcSEcCtD
Naratriptan—Vaginal infection—Doxorubicin—uterine cancer	0.00134	0.00138	CcSEcCtD
Naratriptan—Thrombocytopenia—Dactinomycin—uterine cancer	0.00132	0.00136	CcSEcCtD
Naratriptan—Dry eye—Doxorubicin—uterine cancer	0.00131	0.00135	CcSEcCtD
Naratriptan—Diarrhoea—Progesterone—uterine cancer	0.0013	0.00135	CcSEcCtD
Naratriptan—MAOA—female reproductive system—uterine cancer	0.0013	0.0385	CbGeAlD
Naratriptan—Oesophagitis—Doxorubicin—uterine cancer	0.00129	0.00134	CcSEcCtD
Naratriptan—Bladder pain—Doxorubicin—uterine cancer	0.00128	0.00132	CcSEcCtD
Naratriptan—Cardiac disorder—Etoposide—uterine cancer	0.00127	0.00132	CcSEcCtD
Naratriptan—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00127	0.00131	CcSEcCtD
Naratriptan—Photosensitivity—Epirubicin—uterine cancer	0.00126	0.00131	CcSEcCtD
Naratriptan—Dizziness—Progesterone—uterine cancer	0.00126	0.0013	CcSEcCtD
Naratriptan—Angiopathy—Etoposide—uterine cancer	0.00124	0.00129	CcSEcCtD
Naratriptan—Vascular purpura—Epirubicin—uterine cancer	0.00124	0.00128	CcSEcCtD
Naratriptan—Immune system disorder—Etoposide—uterine cancer	0.00124	0.00128	CcSEcCtD
Naratriptan—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00124	0.00128	CcSEcCtD
Naratriptan—Eye pain—Epirubicin—uterine cancer	0.00123	0.00127	CcSEcCtD
Naratriptan—Chills—Etoposide—uterine cancer	0.00123	0.00127	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.00123	0.00127	CcSEcCtD
Naratriptan—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00122	0.00126	CcSEcCtD
Naratriptan—Alopecia—Etoposide—uterine cancer	0.00121	0.00125	CcSEcCtD
Naratriptan—Vomiting—Progesterone—uterine cancer	0.00121	0.00125	CcSEcCtD
Naratriptan—Rash—Progesterone—uterine cancer	0.0012	0.00124	CcSEcCtD
Naratriptan—Dermatitis—Progesterone—uterine cancer	0.0012	0.00124	CcSEcCtD
Naratriptan—Headache—Progesterone—uterine cancer	0.00119	0.00123	CcSEcCtD
Naratriptan—MAOA—female gonad—uterine cancer	0.00118	0.035	CbGeAlD
Naratriptan—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00118	0.00122	CcSEcCtD
Naratriptan—MAOA—vagina—uterine cancer	0.00118	0.0348	CbGeAlD
Naratriptan—Photosensitivity—Doxorubicin—uterine cancer	0.00117	0.00121	CcSEcCtD
Naratriptan—Fatigue—Dactinomycin—uterine cancer	0.00116	0.0012	CcSEcCtD
Naratriptan—Purpura—Epirubicin—uterine cancer	0.00115	0.00119	CcSEcCtD
Naratriptan—Pain—Dactinomycin—uterine cancer	0.00115	0.00119	CcSEcCtD
Naratriptan—Vascular purpura—Doxorubicin—uterine cancer	0.00115	0.00119	CcSEcCtD
Naratriptan—Anaphylactoid reaction—Epirubicin—uterine cancer	0.00115	0.00119	CcSEcCtD
Naratriptan—Muscle spasms—Etoposide—uterine cancer	0.00115	0.00119	CcSEcCtD
Naratriptan—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00114	0.00118	CcSEcCtD
Naratriptan—Eye pain—Doxorubicin—uterine cancer	0.00114	0.00118	CcSEcCtD
Naratriptan—Cerebrovascular accident—Epirubicin—uterine cancer	0.00113	0.00117	CcSEcCtD
Naratriptan—Nausea—Progesterone—uterine cancer	0.00113	0.00117	CcSEcCtD
Naratriptan—Feeling abnormal—Dactinomycin—uterine cancer	0.00111	0.00115	CcSEcCtD
Naratriptan—Ill-defined disorder—Etoposide—uterine cancer	0.00111	0.00115	CcSEcCtD
Naratriptan—Anaemia—Etoposide—uterine cancer	0.0011	0.00114	CcSEcCtD
Naratriptan—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.0011	0.00113	CcSEcCtD
Naratriptan—Migraine—Epirubicin—uterine cancer	0.00109	0.00113	CcSEcCtD
Naratriptan—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00109	0.00112	CcSEcCtD
Naratriptan—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00109	0.00112	CcSEcCtD
Naratriptan—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00108	0.00112	CcSEcCtD
Naratriptan—Malaise—Etoposide—uterine cancer	0.00108	0.00111	CcSEcCtD
Naratriptan—Vertigo—Etoposide—uterine cancer	0.00107	0.00111	CcSEcCtD
Naratriptan—Purpura—Doxorubicin—uterine cancer	0.00107	0.0011	CcSEcCtD
Naratriptan—Body temperature increased—Dactinomycin—uterine cancer	0.00106	0.0011	CcSEcCtD
Naratriptan—Anaphylactoid reaction—Doxorubicin—uterine cancer	0.00106	0.0011	CcSEcCtD
Naratriptan—Loss of consciousness—Etoposide—uterine cancer	0.00105	0.00108	CcSEcCtD
Naratriptan—Cerebrovascular accident—Doxorubicin—uterine cancer	0.00105	0.00108	CcSEcCtD
Naratriptan—Cough—Etoposide—uterine cancer	0.00104	0.00108	CcSEcCtD
Naratriptan—Convulsion—Etoposide—uterine cancer	0.00103	0.00107	CcSEcCtD
Naratriptan—Dehydration—Epirubicin—uterine cancer	0.00103	0.00107	CcSEcCtD
Naratriptan—Liver function test abnormal—Epirubicin—uterine cancer	0.00102	0.00106	CcSEcCtD
Naratriptan—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00102	0.00106	CcSEcCtD
Naratriptan—Dry skin—Epirubicin—uterine cancer	0.00102	0.00105	CcSEcCtD
Naratriptan—Migraine—Doxorubicin—uterine cancer	0.00101	0.00105	CcSEcCtD
Naratriptan—Discomfort—Etoposide—uterine cancer	0.001	0.00104	CcSEcCtD
Naratriptan—Hypersensitivity—Dactinomycin—uterine cancer	0.000991	0.00103	CcSEcCtD
Naratriptan—Gastritis—Epirubicin—uterine cancer	0.000982	0.00102	CcSEcCtD
Naratriptan—Confusional state—Etoposide—uterine cancer	0.000981	0.00102	CcSEcCtD
Naratriptan—Anaphylactic shock—Etoposide—uterine cancer	0.000973	0.00101	CcSEcCtD
Naratriptan—Infection—Etoposide—uterine cancer	0.000967	0.001	CcSEcCtD
Naratriptan—Asthenia—Dactinomycin—uterine cancer	0.000965	0.000998	CcSEcCtD
Naratriptan—Asthma—Epirubicin—uterine cancer	0.000959	0.000993	CcSEcCtD
Naratriptan—Dehydration—Doxorubicin—uterine cancer	0.000955	0.000988	CcSEcCtD
Naratriptan—Thrombocytopenia—Etoposide—uterine cancer	0.000953	0.000986	CcSEcCtD
Naratriptan—Liver function test abnormal—Doxorubicin—uterine cancer	0.000948	0.000981	CcSEcCtD
Naratriptan—Skin disorder—Etoposide—uterine cancer	0.000945	0.000978	CcSEcCtD
Naratriptan—Dry skin—Doxorubicin—uterine cancer	0.000941	0.000974	CcSEcCtD
Naratriptan—Hyperhidrosis—Etoposide—uterine cancer	0.000941	0.000974	CcSEcCtD
Naratriptan—Angina pectoris—Epirubicin—uterine cancer	0.000935	0.000967	CcSEcCtD
Naratriptan—Bronchitis—Epirubicin—uterine cancer	0.000923	0.000955	CcSEcCtD
Naratriptan—Diarrhoea—Dactinomycin—uterine cancer	0.00092	0.000952	CcSEcCtD
Naratriptan—Hypotension—Etoposide—uterine cancer	0.000909	0.000941	CcSEcCtD
Naratriptan—Gastritis—Doxorubicin—uterine cancer	0.000909	0.000941	CcSEcCtD
Naratriptan—Asthma—Doxorubicin—uterine cancer	0.000888	0.000919	CcSEcCtD
Naratriptan—Pollakiuria—Epirubicin—uterine cancer	0.000886	0.000917	CcSEcCtD
Naratriptan—Photosensitivity reaction—Epirubicin—uterine cancer	0.000876	0.000906	CcSEcCtD
Naratriptan—Paraesthesia—Etoposide—uterine cancer	0.000874	0.000904	CcSEcCtD
Naratriptan—Dyspnoea—Etoposide—uterine cancer	0.000868	0.000898	CcSEcCtD
Naratriptan—Hyperglycaemia—Epirubicin—uterine cancer	0.000865	0.000896	CcSEcCtD
Naratriptan—Somnolence—Etoposide—uterine cancer	0.000865	0.000895	CcSEcCtD
Naratriptan—Angina pectoris—Doxorubicin—uterine cancer	0.000865	0.000895	CcSEcCtD
Naratriptan—Pneumonia—Epirubicin—uterine cancer	0.00086	0.00089	CcSEcCtD
Naratriptan—Drowsiness—Epirubicin—uterine cancer	0.000855	0.000885	CcSEcCtD
Naratriptan—Vomiting—Dactinomycin—uterine cancer	0.000855	0.000885	CcSEcCtD
Naratriptan—Bronchitis—Doxorubicin—uterine cancer	0.000854	0.000883	CcSEcCtD
Naratriptan—Rash—Dactinomycin—uterine cancer	0.000848	0.000877	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Etoposide—uterine cancer	0.00084	0.00087	CcSEcCtD
Naratriptan—Fatigue—Etoposide—uterine cancer	0.000839	0.000868	CcSEcCtD
Naratriptan—Neuropathy peripheral—Epirubicin—uterine cancer	0.000838	0.000868	CcSEcCtD
Naratriptan—Constipation—Etoposide—uterine cancer	0.000832	0.000861	CcSEcCtD
Naratriptan—Pain—Etoposide—uterine cancer	0.000832	0.000861	CcSEcCtD
Naratriptan—Sweating—Epirubicin—uterine cancer	0.00082	0.000849	CcSEcCtD
Naratriptan—Pollakiuria—Doxorubicin—uterine cancer	0.00082	0.000849	CcSEcCtD
Naratriptan—Photosensitivity reaction—Doxorubicin—uterine cancer	0.00081	0.000839	CcSEcCtD
Naratriptan—Sinusitis—Epirubicin—uterine cancer	0.000802	0.000831	CcSEcCtD
Naratriptan—Feeling abnormal—Etoposide—uterine cancer	0.000802	0.00083	CcSEcCtD
Naratriptan—Hyperglycaemia—Doxorubicin—uterine cancer	0.000801	0.000829	CcSEcCtD
Naratriptan—Nausea—Dactinomycin—uterine cancer	0.000799	0.000827	CcSEcCtD
Naratriptan—Pneumonia—Doxorubicin—uterine cancer	0.000796	0.000824	CcSEcCtD
Naratriptan—Drowsiness—Doxorubicin—uterine cancer	0.000791	0.000819	CcSEcCtD
Naratriptan—Bradycardia—Epirubicin—uterine cancer	0.000782	0.000809	CcSEcCtD
Naratriptan—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000776	0.000803	CcSEcCtD
Naratriptan—Urticaria—Etoposide—uterine cancer	0.000773	0.0008	CcSEcCtD
Naratriptan—Haemoglobin—Epirubicin—uterine cancer	0.000772	0.000799	CcSEcCtD
Naratriptan—Body temperature increased—Etoposide—uterine cancer	0.000769	0.000796	CcSEcCtD
Naratriptan—Haemorrhage—Epirubicin—uterine cancer	0.000768	0.000795	CcSEcCtD
Naratriptan—Hypoaesthesia—Epirubicin—uterine cancer	0.000764	0.000791	CcSEcCtD
Naratriptan—MAOA—lymph node—uterine cancer	0.00076	0.0225	CbGeAlD
Naratriptan—Sweating—Doxorubicin—uterine cancer	0.000759	0.000785	CcSEcCtD
Naratriptan—Sinusitis—Doxorubicin—uterine cancer	0.000743	0.000768	CcSEcCtD
Naratriptan—Bradycardia—Doxorubicin—uterine cancer	0.000723	0.000749	CcSEcCtD
Naratriptan—Hypersensitivity—Etoposide—uterine cancer	0.000717	0.000742	CcSEcCtD
Naratriptan—Tinnitus—Epirubicin—uterine cancer	0.000716	0.000741	CcSEcCtD
Naratriptan—Haemoglobin—Doxorubicin—uterine cancer	0.000714	0.000739	CcSEcCtD
Naratriptan—Cardiac disorder—Epirubicin—uterine cancer	0.000713	0.000738	CcSEcCtD
Naratriptan—Haemorrhage—Doxorubicin—uterine cancer	0.000711	0.000735	CcSEcCtD
Naratriptan—Hypoaesthesia—Doxorubicin—uterine cancer	0.000707	0.000732	CcSEcCtD
Naratriptan—Asthenia—Etoposide—uterine cancer	0.000698	0.000723	CcSEcCtD
Naratriptan—Angiopathy—Epirubicin—uterine cancer	0.000697	0.000721	CcSEcCtD
Naratriptan—Immune system disorder—Epirubicin—uterine cancer	0.000694	0.000718	CcSEcCtD
Naratriptan—Chills—Epirubicin—uterine cancer	0.000689	0.000713	CcSEcCtD
Naratriptan—Pruritus—Etoposide—uterine cancer	0.000689	0.000713	CcSEcCtD
Naratriptan—Arrhythmia—Epirubicin—uterine cancer	0.000686	0.00071	CcSEcCtD
Naratriptan—Alopecia—Epirubicin—uterine cancer	0.000679	0.000702	CcSEcCtD
Naratriptan—Erythema—Epirubicin—uterine cancer	0.000668	0.000692	CcSEcCtD
Naratriptan—Diarrhoea—Etoposide—uterine cancer	0.000666	0.000689	CcSEcCtD
Naratriptan—Tinnitus—Doxorubicin—uterine cancer	0.000662	0.000686	CcSEcCtD
Naratriptan—Cardiac disorder—Doxorubicin—uterine cancer	0.000659	0.000682	CcSEcCtD
Naratriptan—Angiopathy—Doxorubicin—uterine cancer	0.000645	0.000667	CcSEcCtD
Naratriptan—Dizziness—Etoposide—uterine cancer	0.000644	0.000666	CcSEcCtD
Naratriptan—Muscle spasms—Epirubicin—uterine cancer	0.000643	0.000665	CcSEcCtD
Naratriptan—Immune system disorder—Doxorubicin—uterine cancer	0.000642	0.000664	CcSEcCtD
Naratriptan—Chills—Doxorubicin—uterine cancer	0.000638	0.00066	CcSEcCtD
Naratriptan—Arrhythmia—Doxorubicin—uterine cancer	0.000635	0.000657	CcSEcCtD
Naratriptan—Vision blurred—Epirubicin—uterine cancer	0.00063	0.000652	CcSEcCtD
Naratriptan—Alopecia—Doxorubicin—uterine cancer	0.000628	0.00065	CcSEcCtD
Naratriptan—Ill-defined disorder—Epirubicin—uterine cancer	0.00062	0.000642	CcSEcCtD
Naratriptan—Vomiting—Etoposide—uterine cancer	0.000619	0.00064	CcSEcCtD
Naratriptan—Erythema—Doxorubicin—uterine cancer	0.000618	0.00064	CcSEcCtD
Naratriptan—Anaemia—Epirubicin—uterine cancer	0.000618	0.000639	CcSEcCtD
Naratriptan—Agitation—Epirubicin—uterine cancer	0.000614	0.000636	CcSEcCtD
Naratriptan—Rash—Etoposide—uterine cancer	0.000614	0.000635	CcSEcCtD
Naratriptan—Dermatitis—Etoposide—uterine cancer	0.000613	0.000634	CcSEcCtD
Naratriptan—Headache—Etoposide—uterine cancer	0.00061	0.000631	CcSEcCtD
Naratriptan—Malaise—Epirubicin—uterine cancer	0.000603	0.000624	CcSEcCtD
Naratriptan—Vertigo—Epirubicin—uterine cancer	0.000601	0.000622	CcSEcCtD
Naratriptan—Syncope—Epirubicin—uterine cancer	0.000599	0.00062	CcSEcCtD
Naratriptan—Muscle spasms—Doxorubicin—uterine cancer	0.000595	0.000615	CcSEcCtD
Naratriptan—Palpitations—Epirubicin—uterine cancer	0.000591	0.000611	CcSEcCtD
Naratriptan—Loss of consciousness—Epirubicin—uterine cancer	0.000588	0.000608	CcSEcCtD
Naratriptan—Cough—Epirubicin—uterine cancer	0.000583	0.000604	CcSEcCtD
Naratriptan—Vision blurred—Doxorubicin—uterine cancer	0.000583	0.000603	CcSEcCtD
Naratriptan—Convulsion—Epirubicin—uterine cancer	0.000579	0.000599	CcSEcCtD
Naratriptan—Nausea—Etoposide—uterine cancer	0.000578	0.000598	CcSEcCtD
Naratriptan—Ill-defined disorder—Doxorubicin—uterine cancer	0.000574	0.000594	CcSEcCtD
Naratriptan—Anaemia—Doxorubicin—uterine cancer	0.000572	0.000592	CcSEcCtD
Naratriptan—Arthralgia—Epirubicin—uterine cancer	0.000569	0.000589	CcSEcCtD
Naratriptan—Myalgia—Epirubicin—uterine cancer	0.000569	0.000589	CcSEcCtD
Naratriptan—Agitation—Doxorubicin—uterine cancer	0.000568	0.000588	CcSEcCtD
Naratriptan—Anxiety—Epirubicin—uterine cancer	0.000567	0.000587	CcSEcCtD
Naratriptan—Discomfort—Epirubicin—uterine cancer	0.000562	0.000582	CcSEcCtD
Naratriptan—Malaise—Doxorubicin—uterine cancer	0.000558	0.000577	CcSEcCtD
Naratriptan—Dry mouth—Epirubicin—uterine cancer	0.000557	0.000576	CcSEcCtD
Naratriptan—Vertigo—Doxorubicin—uterine cancer	0.000556	0.000575	CcSEcCtD
Naratriptan—Syncope—Doxorubicin—uterine cancer	0.000555	0.000574	CcSEcCtD
Naratriptan—Confusional state—Epirubicin—uterine cancer	0.00055	0.000569	CcSEcCtD
Naratriptan—Palpitations—Doxorubicin—uterine cancer	0.000547	0.000566	CcSEcCtD
Naratriptan—Anaphylactic shock—Epirubicin—uterine cancer	0.000546	0.000565	CcSEcCtD
Naratriptan—Oedema—Epirubicin—uterine cancer	0.000546	0.000565	CcSEcCtD
Naratriptan—Loss of consciousness—Doxorubicin—uterine cancer	0.000544	0.000563	CcSEcCtD
Naratriptan—Infection—Epirubicin—uterine cancer	0.000542	0.000561	CcSEcCtD
Naratriptan—Cough—Doxorubicin—uterine cancer	0.00054	0.000559	CcSEcCtD
Naratriptan—Shock—Epirubicin—uterine cancer	0.000537	0.000555	CcSEcCtD
Naratriptan—Convulsion—Doxorubicin—uterine cancer	0.000536	0.000555	CcSEcCtD
Naratriptan—Nervous system disorder—Epirubicin—uterine cancer	0.000535	0.000554	CcSEcCtD
Naratriptan—Thrombocytopenia—Epirubicin—uterine cancer	0.000534	0.000553	CcSEcCtD
Naratriptan—Skin disorder—Epirubicin—uterine cancer	0.00053	0.000548	CcSEcCtD
Naratriptan—Hyperhidrosis—Epirubicin—uterine cancer	0.000527	0.000546	CcSEcCtD
Naratriptan—Myalgia—Doxorubicin—uterine cancer	0.000527	0.000545	CcSEcCtD
Naratriptan—Arthralgia—Doxorubicin—uterine cancer	0.000527	0.000545	CcSEcCtD
Naratriptan—Anxiety—Doxorubicin—uterine cancer	0.000525	0.000543	CcSEcCtD
Naratriptan—Discomfort—Doxorubicin—uterine cancer	0.00052	0.000538	CcSEcCtD
Naratriptan—Dry mouth—Doxorubicin—uterine cancer	0.000515	0.000533	CcSEcCtD
Naratriptan—Hypotension—Epirubicin—uterine cancer	0.00051	0.000528	CcSEcCtD
Naratriptan—Confusional state—Doxorubicin—uterine cancer	0.000509	0.000527	CcSEcCtD
Naratriptan—Anaphylactic shock—Doxorubicin—uterine cancer	0.000505	0.000522	CcSEcCtD
Naratriptan—Oedema—Doxorubicin—uterine cancer	0.000505	0.000522	CcSEcCtD
Naratriptan—Infection—Doxorubicin—uterine cancer	0.000501	0.000519	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000497	0.000514	CcSEcCtD
Naratriptan—Shock—Doxorubicin—uterine cancer	0.000497	0.000514	CcSEcCtD
Naratriptan—Nervous system disorder—Doxorubicin—uterine cancer	0.000495	0.000512	CcSEcCtD
Naratriptan—Thrombocytopenia—Doxorubicin—uterine cancer	0.000494	0.000511	CcSEcCtD
Naratriptan—Skin disorder—Doxorubicin—uterine cancer	0.00049	0.000507	CcSEcCtD
Naratriptan—Paraesthesia—Epirubicin—uterine cancer	0.00049	0.000507	CcSEcCtD
Naratriptan—Hyperhidrosis—Doxorubicin—uterine cancer	0.000488	0.000505	CcSEcCtD
Naratriptan—Dyspnoea—Epirubicin—uterine cancer	0.000486	0.000503	CcSEcCtD
Naratriptan—Somnolence—Epirubicin—uterine cancer	0.000485	0.000502	CcSEcCtD
Naratriptan—Hypotension—Doxorubicin—uterine cancer	0.000472	0.000488	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000471	0.000487	CcSEcCtD
Naratriptan—Fatigue—Epirubicin—uterine cancer	0.00047	0.000487	CcSEcCtD
Naratriptan—Pain—Epirubicin—uterine cancer	0.000467	0.000483	CcSEcCtD
Naratriptan—Constipation—Epirubicin—uterine cancer	0.000467	0.000483	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.00046	0.000476	CcSEcCtD
Naratriptan—Paraesthesia—Doxorubicin—uterine cancer	0.000453	0.000469	CcSEcCtD
Naratriptan—Dyspnoea—Doxorubicin—uterine cancer	0.00045	0.000466	CcSEcCtD
Naratriptan—Feeling abnormal—Epirubicin—uterine cancer	0.00045	0.000465	CcSEcCtD
Naratriptan—Somnolence—Doxorubicin—uterine cancer	0.000449	0.000464	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000436	0.000451	CcSEcCtD
Naratriptan—Fatigue—Doxorubicin—uterine cancer	0.000435	0.00045	CcSEcCtD
Naratriptan—Urticaria—Epirubicin—uterine cancer	0.000433	0.000449	CcSEcCtD
Naratriptan—Pain—Doxorubicin—uterine cancer	0.000432	0.000447	CcSEcCtD
Naratriptan—Constipation—Doxorubicin—uterine cancer	0.000432	0.000447	CcSEcCtD
Naratriptan—Body temperature increased—Epirubicin—uterine cancer	0.000431	0.000446	CcSEcCtD
Naratriptan—Feeling abnormal—Doxorubicin—uterine cancer	0.000416	0.000431	CcSEcCtD
Naratriptan—Hypersensitivity—Epirubicin—uterine cancer	0.000402	0.000416	CcSEcCtD
Naratriptan—Urticaria—Doxorubicin—uterine cancer	0.000401	0.000415	CcSEcCtD
Naratriptan—Body temperature increased—Doxorubicin—uterine cancer	0.000399	0.000413	CcSEcCtD
Naratriptan—Asthenia—Epirubicin—uterine cancer	0.000391	0.000405	CcSEcCtD
Naratriptan—Pruritus—Epirubicin—uterine cancer	0.000386	0.000399	CcSEcCtD
Naratriptan—Diarrhoea—Epirubicin—uterine cancer	0.000373	0.000386	CcSEcCtD
Naratriptan—Hypersensitivity—Doxorubicin—uterine cancer	0.000372	0.000385	CcSEcCtD
Naratriptan—Asthenia—Doxorubicin—uterine cancer	0.000362	0.000375	CcSEcCtD
Naratriptan—Dizziness—Epirubicin—uterine cancer	0.000361	0.000373	CcSEcCtD
Naratriptan—Pruritus—Doxorubicin—uterine cancer	0.000357	0.00037	CcSEcCtD
Naratriptan—Vomiting—Epirubicin—uterine cancer	0.000347	0.000359	CcSEcCtD
Naratriptan—Diarrhoea—Doxorubicin—uterine cancer	0.000345	0.000357	CcSEcCtD
Naratriptan—Rash—Epirubicin—uterine cancer	0.000344	0.000356	CcSEcCtD
Naratriptan—Dermatitis—Epirubicin—uterine cancer	0.000344	0.000356	CcSEcCtD
Naratriptan—Headache—Epirubicin—uterine cancer	0.000342	0.000354	CcSEcCtD
Naratriptan—Dizziness—Doxorubicin—uterine cancer	0.000334	0.000345	CcSEcCtD
Naratriptan—Nausea—Epirubicin—uterine cancer	0.000324	0.000335	CcSEcCtD
Naratriptan—Vomiting—Doxorubicin—uterine cancer	0.000321	0.000332	CcSEcCtD
Naratriptan—Rash—Doxorubicin—uterine cancer	0.000318	0.000329	CcSEcCtD
Naratriptan—Dermatitis—Doxorubicin—uterine cancer	0.000318	0.000329	CcSEcCtD
Naratriptan—Headache—Doxorubicin—uterine cancer	0.000316	0.000327	CcSEcCtD
Naratriptan—Nausea—Doxorubicin—uterine cancer	0.0003	0.00031	CcSEcCtD
